Timeline
Hemogenyx Pharmaceuticals
Hemogenyx signs Lithuania hospital deal for CAR-T therapy
Hemogenyx Pharmaceuticals shares fall after £3m fundraising
More in Biotech
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.